Fundraising FoxSapir Venture Partners — 2017 Investments
1 investments dated 2017 · listed companies and verified rows first · show all
SynVaccinesynvaccine.comNov 2017
SynVaccine develops technology for the computer-aided design and construction of viral genomes, applying synthetic and computational biology to create viral-based products such as vaccines and viral-based therapeutics.
AI & Machine LearningBiotechDeep TechHealthtechMedical Devices
Tamir Tuller(Co-founder & CSO)Oren Bogin(Interim CEO)David Zigdon(Executive Chairman)
Co-investorsPix Vine Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.